Aravive

Aravive is a private, late-stage preclinical biopharmaceutical company dedicated to developing novel, highly selective cancer therapies that target severe malignancies while sparing normal healthy cells.On November 21, 2016, the company changed its name from Ruga Corporation to Aravive Biologics, Inc., and subsequently renamed itself Aravive, Inc.